Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function
Clinical trial NCT04469920 · COMPLETED
Trial details
- NCT number
- NCT04469920
- Sponsor
- Zydus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2022-03-21
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.